Risks with Cytoreductive Therapy

Laura C. Michaelis, MD

Video Categories: Polycythemia Vera

Hear Dr. Michaelis discuss cytoreductive therapy and the risk factor for patients with hemorrhage.

Supported through funding from Incyte
July 25, 2018

Best Practices in How Oncologists and Pathologists Can Work Together to Optimize Biomarker Testing for their Patients with Cancer

Dr Sanjiv Agarwala describes best practices developed at St. Luke’s Cancer Center, where a committee has been formed in which clinicians and pathologists meet to reach consensus on reflex testing of molecular biomarkers, as well as the value of biomarker testing in enhancing patient care.

September 20, 2013

Developing an Accurate Price Model for Personalized Medicines

Randy Vogenberg discusses the complexities of developing pricing for personalized medicine products